3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年12月31日)
|
当連結会計年度
(2025年12月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
3,963,580
|
2,883,503
|
|
|
|
売掛金
|
423,153
|
259,676
|
|
|
|
商品及び製品
|
115,188
|
152,551
|
|
|
|
半製品
|
61,798
|
-
|
|
|
|
貯蔵品
|
61,933
|
136,396
|
|
|
|
前渡金
|
115,126
|
259,963
|
|
|
|
前払費用
|
110,947
|
60,276
|
|
|
|
その他
|
72,503
|
71,681
|
|
|
|
流動資産合計
|
4,924,231
|
3,824,049
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物
|
172,767
|
172,767
|
|
|
|
|
|
減価償却累計額
|
△172,767
|
△172,767
|
|
|
|
|
|
建物(純額)
|
-
|
-
|
|
|
|
|
工具、器具及び備品
|
107,247
|
81,353
|
|
|
|
|
|
減価償却累計額
|
△107,247
|
△81,353
|
|
|
|
|
|
工具、器具及び備品(純額)
|
-
|
-
|
|
|
|
|
有形固定資産合計
|
-
|
-
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
関係会社株式
|
-
|
15
|
|
|
|
|
敷金及び保証金
|
44,102
|
37,349
|
|
|
|
|
繰延税金資産
|
-
|
5,902
|
|
|
|
|
投資その他の資産合計
|
44,102
|
43,267
|
|
|
|
固定資産合計
|
44,102
|
43,267
|
|
|
資産合計
|
4,968,333
|
3,867,316
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年12月31日)
|
当連結会計年度
(2025年12月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
未払金
|
635,852
|
468,270
|
|
|
|
未払法人税等
|
102,006
|
118,550
|
|
|
|
1年内償還予定の社債
|
-
|
682,500
|
|
|
|
その他
|
28,310
|
21,045
|
|
|
|
流動負債合計
|
766,169
|
1,290,365
|
|
|
固定負債
|
|
|
|
|
|
転換社債型新株予約権付社債
|
-
|
1,300,000
|
|
|
|
退職給付に係る負債
|
4,603
|
4,911
|
|
|
|
固定負債合計
|
4,603
|
1,304,911
|
|
|
負債合計
|
770,772
|
2,595,276
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
18,336,841
|
19,244,128
|
|
|
|
資本剰余金
|
18,311,713
|
19,218,965
|
|
|
|
利益剰余金
|
△32,685,784
|
△37,461,978
|
|
|
|
自己株式
|
△89,863
|
△89,870
|
|
|
|
株主資本合計
|
3,872,907
|
911,244
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
為替換算調整勘定
|
7,894
|
12,925
|
|
|
|
その他の包括利益累計額合計
|
7,894
|
12,925
|
|
|
新株予約権
|
316,758
|
347,869
|
|
|
純資産合計
|
4,197,560
|
1,272,040
|
|
負債純資産合計
|
4,968,333
|
3,867,316
|
E24682
45820
シンバイオ製薬株式会社
SymBio Pharmaceuticals Limited
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-01-01
2025-12-31
FY
2025-12-31
2024-01-01
2024-12-31
2024-12-31
1
false
false
false
45820
2026-02-05
45820
2025-01-01
2025-12-31
45820
2025-01-01
2025-12-31
jppfs_cor:CapitalStockMember
45820
2025-01-01
2025-12-31
jppfs_cor:CapitalSurplusMember
45820
2025-01-01
2025-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45820
2025-01-01
2025-12-31
jppfs_cor:RetainedEarningsMember
45820
2025-01-01
2025-12-31
jppfs_cor:ShareholdersEquityMember
45820
2025-01-01
2025-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45820
2025-01-01
2025-12-31
jppfs_cor:TreasuryStockMember
45820
2025-01-01
2025-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45820
2025-12-31
45820
2025-12-31
jppfs_cor:CapitalStockMember
45820
2025-12-31
jppfs_cor:CapitalSurplusMember
45820
2025-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45820
2025-12-31
jppfs_cor:RetainedEarningsMember
45820
2025-12-31
jppfs_cor:ShareholdersEquityMember
45820
2025-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45820
2025-12-31
jppfs_cor:TreasuryStockMember
45820
2025-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45820
2024-01-01
2024-12-31
45820
2024-01-01
2024-12-31
jppfs_cor:CapitalStockMember
45820
2024-01-01
2024-12-31
jppfs_cor:CapitalSurplusMember
45820
2024-01-01
2024-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45820
2024-01-01
2024-12-31
jppfs_cor:RetainedEarningsMember
45820
2024-01-01
2024-12-31
jppfs_cor:ShareholdersEquityMember
45820
2024-01-01
2024-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45820
2024-01-01
2024-12-31
jppfs_cor:TreasuryStockMember
45820
2024-01-01
2024-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45820
2024-12-31
45820
2024-12-31
jppfs_cor:CapitalStockMember
45820
2024-12-31
jppfs_cor:CapitalSurplusMember
45820
2024-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45820
2024-12-31
jppfs_cor:RetainedEarningsMember
45820
2024-12-31
jppfs_cor:ShareholdersEquityMember
45820
2024-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45820
2024-12-31
jppfs_cor:TreasuryStockMember
45820
2024-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45820
2023-12-31
45820
2023-12-31
jppfs_cor:CapitalStockMember
45820
2023-12-31
jppfs_cor:CapitalSurplusMember
45820
2023-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45820
2023-12-31
jppfs_cor:RetainedEarningsMember
45820
2023-12-31
jppfs_cor:ShareholdersEquityMember
45820
2023-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45820
2023-12-31
jppfs_cor:TreasuryStockMember
45820
2023-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
iso4217:JPY
xbrli:pure